Increased osteoclastogenesis gives rise to localized bone resorption and the release of cytokines and growth factors from the bone matrix that stimulate tumor cell growth and further enhance the RANK-RANKL signaling cascade to promote bone resorption [4], resulting in overt tumor-induced bone disease. The gene discussed is TNFRSF11A; the disease is neoplasm.